What's New in Research Funding

Page last updated March 21, 2017.

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates:

March 21, 2017

  • George Weston & Loblaw Companies: Seeding Food Innovation 2017. This funding opportunity supports funding for rigorously scientific, trans-disciplinary research proposals that investigate food and health challenges that will impact primarily Canadians, but also deliver key learnings to solve issues of global concern. Funding of up to $150,000 per project is available for up to two years within the field of food innovation. Grants will only be awarded to institutions that are Canada Revenue Agency registered. Internal Deadline for LOIs: April 10, 2017; Sponsor Deadline: April 17, 2017.
  • The Ministry of Research, Innovation and Science (MRIS): Ontario Research Fund - Research Excellence Round 9. The ORF-RE program promotes research excellence of strategic value to Ontario by supporting new leading-edge, transformative, and internationally significant research. The ORF-RE focuses on research excellence and strong benefits to Ontario with this program that requires significant Private Sector partnership. The program will contribute towards eligible operating costs of an approved research project to a maximum of 1/3 of the total project costs, with 1/3 of the remainder coming from the applicant institution(s) and 1/3 from the private sector. Mandatory NoIs are to be submitted to Research Services (no MRA required) by April 25, 2017. View the funding opportunity for further details.
  • CIHR Team Grant: Human Immunology Initiative: Standardization and its application in autoimmune diseases research. The aim of the Standardization Core is to create common measurements, indicators and outcomes that can be used for comparative purposes across populations and studies, including identifying and addressing ethical issues. The successful applicant to the Standardization Core funding opportunity will constitute a best practices platform, and will be responsible for the development and validation of standard operating procedures (SOPs) in human immunology, applied to the field of autoimmune disease research, by aligning with work conducted at the international level.
  • CIFAR Azrieli Global Scholars Program. CIFAR announces a new opportunity for early career researchers.  This initiative invites outstanding early-career researchers to join one of nine research programs which address some of the most complex challenges facing the world today. The CIFAR Azrieli Global Scholars program provides funding and support to help you build your research network at this early stage in your career. The award includes a two-year appointment to a CIFAR program, $100,000 CDN in undesignated research support, and specialized leadership and communications training. Scholars are appointed to a research program, becoming part of a global network of leading researchers pursuing answers to some of the most difficult challenges facing the world today. Please visit their website for eligibility requirements, guidelines and eligible research themes. Questions should be directed to global.scholars@cifar.ca. Deadline for Submissions: May 23, 2017.
  • Canadian Liver Foundation: Operating Grants. Two operating grants may be awarded to researchers in Canada whose research projects are related to hepatobiliary research. One operating grant may be awarded to a researcher in Canada whose research project is related to liver cancer, and one operating grant (sponsored by F. Pauline Spence) may be awarded to a researcher in Ontario whose research project is related to hepatobiliary research. Deadline for Applications: March 31, 2017.
  • Bill and Melinda Gates Foundation: Grand Challenges Exploration (Round 19). GCE supports early-stage research projects - including many ideas that have never before been tested. The GCE initiative funds innovative ideas that could lead to new vaccines, diagnostics, drugs, and other technologies targeting diseases that claim millions of lives every year, as well as improvements and innovations in agriculture development and others of the Foundation priority areas. Deadline for Submissions: May 3, 2017. GCE round 19 challenges are:
  • Worldwide Cancer Research: Research Grants. The sponsor's goal is to fund scientific research that may, in future, help reduce the incidence of cancer or improve cancer survival. The sponsor awards project grants to support basic or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer. This definition is usually interpreted conservatively. Worldwide Cancer Research does not accept applications for clinical or psychosocial research and other types of applied cancer research. Upper amount: £250,000GBP for 1-3 years. Deadline for Submissions: April 21, 2017 at 17:00 British Summer Time.
  •  ALS Association and CReATe Consortium. Biomarker Development Validation: 2017 Request for Applications. The purpose of this RFA is to support the discovery and/or validation of biomarkers that are relevant to the development of therapies for patients with ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]). Proposals to develop either wet (e.g. biological-fluid based) or dry (e.g. neuroimaging, neurophysiological) biomarkers are encouraged. Investigators submitting an application in response to this RFA may also request to use the data and/or biological samples collected by the CReATe Consortium. Any individual with the requisite scientific training, irrespective of country of residence or origin, may submit an application in response to this RFA. Upper Amount: $60,000 USD. Deadline for Letters of Intent: April 7, 2017.
  • ALS Association: Translational Research Advancing Therapy for ALS (TREAT ALS) / The Lawrence and Isabel Barnett Drug Development Program - BRIDGE GRANTS. The ALS Association's TREAT ALSTM program funds research from early target identification to preclinical research and early pilot clinical trials. As part of the program, The Association is requesting letters of intent for its drug development contract program, milestone driven research to develop new treatments for ALS. The program compliments the Department of Defense ALS research program and the translational programs at the National Institutes of Health and specifically aims to support studies that will de-risk and incentive industry partners to further pursue interesting targets. Upper amount: $500,000 USD; Lower $50,000 USD. Deadline for Letters of Intent: May 23, 2017; Deadline for Full Applications: September 4, 2017.


March 8, 2017

  • Catalyst Grant: Population Health Intervention Research Related to the Legalization of Cannabis in Canada (PRE-ANNCOUNCEMENT). This funding opportunity is aimed at helping researchers plan and develop studies on the impact of cannabis legalization (the intervention under study) as an initial step contributing to a future funding program to answer key questions related to the health and social impact of this change in policy. The total amount available for this opportunity is currently $1 million over one year for up to 10 grants. Anticipated Launch Date: April 2017. 
  • CIHR Update from the Chairs of the College of Reviewers. In this update, Dr. Paul Kubes and Dr. Jane Rylett provide an overview of the College Chairs’ progress to date, as well as their plans for the immediate future.
  • HUB Session: Are you thinking about `value for money`of your research? Given the limited resources we are faced with in health care, the ability to apply economic thinking when making a choice or a decision can be beneficial. This talk will introduce economic evaluation, its potential role in research, when to consider to this technique, and a practical example of how economic evaluation has been used to demonstrate value for money. The goal of economic evaluation is to provide another piece of evidence to assist researchers, health providers, decision-makers, and policy-makers in their decision-making process. If you are thinking about “value for money” of your work/research, economic evaluation could be a technique to consider. Registration is required.
    Date: Wednesday, March 16, 12:30pm - 2pm
    Location: MS 2170, Medical Sciences Building, UofT, 1 King's College Circle
  • Joule Innovation Grant Program - Physician-Led Innovations. As a Canadian Medical Association (CMA) company, JouleTM provides physicians with valuable products and services to help them perform at their best. Joule is uniquely positioned to advance physician-led innovation through grant funding, access to mentorship and knowledge-sharing opportunities. Through the Joule Innovation program, CMA members have access to $150,000 in flexible funding to invest in their venture where they need it most—to build a prototype, to commercialize, to scale their initiative—the possibilities are endless. Questions about Joule and the grant program should be directed to Kyle.brown@cma.caDeadline for Applications: May 1, 2017.
  • Cystinosis Research Foundation. The CRF is prepared to fund proposals to improve the immediate care of children and adults with cystinosis and to develop a new understanding and treatment of cystinosis in an effort to help these patients in the future. The Foundation will support bench, translational and clinical research. Deadline for Proposals: April 10, 2017.
  • Sanfilippo Children's Foundation. The mission of the Sanfilippo Children's Foundation is to drive research, enable access to effective treatments and improve the quality of life for Australian children affected by the fatal childhood disease, Sanfilippo Syndrome.  Funding is available for Translation Research Grants and Incubator Grants. Upper Amount $1,500,000 AUD. Deadline for Expressions of Interest: April 3, 2017; Full Proposal Deadline: May 19, 2017.

February 28, 2017

  • CIHR: HIV/AIDS Prevention and Healthy Living Team Grants (PRE-ANNOUNCEMENT). This funding opportunity aims to address the CIHR HIV/AIDS strategic research priority area of biomedical and clinical research. The goal of the HIV/AIDS Prevention and Healthy Living Team Grants is to improve the health of people living with HIV/AIDS in Canada by supporting the development or enhancement of expert teams of investigators and their partners undertaking strategic collaborative, multi-disciplinary biomedical and clinical research relevant to the CIHR HIV/AIDS Strategic Plan. Anticipated Launch Date: April 2017.
  • 2017 Microbiome Summer School: Big Data Analytics for Omics Science - June 18-22, 2017, Québec City. The primary objective of this summer school is to meet the needs in bioinformatic training for the Canadian microbiome research community through introductory “state-of-the-art” bioinformatic courses. Machine learning approaches will be incorporated. This course is aimed at individuals intending to or working in microbiome research with a biomedical/health perspective who want to gain experience in bioinformatics. Applicants are expected to be embarking on bioinformatics related projects or need to use such approaches in their work. Deadline for submission of candidature: March 17, 2017.
  • UofT Completion Award Application. Under the jurisdiction of the Vice-President, Research and Innovation, the General Research Fund supports a number of research initiatives through an annual allocation. One of these initiatives is the University of Toronto Research Completion Award (RCA) program which provides funding to researchers whose SSHRC or NSERC grant has recently expired with an unspent balance that will be transferred to the GRF and who have been unable to complete the research project due to extenuating circumstances or require funds to advance their originally approved research project in order to position themselves for re-application to NSERC or SSHRC. Questions about the RCA program may be directed to jessica.keating@utoronto.ca or 416-978-1614. Deadline for applications through MRA: April 17, 2017.
  • Canadian Centre for Aging and Brain Health Innovation: Researcher Clinician Partnership Program (RCP2). This program is uniquely designed to greatly enhance the effectiveness of connecting point-of-care clinicians in the senior care sector with university-based researchers to collaboratively design, test and validate innovative products, services or health practices in aging and brain health in a real-world care setting.  They are now seeking applicants with innovations that are aimed at finding solutions to specific care priorities for older adults living with dementia and Alzheimer's, or are targeted at improving cognitive fitness in the aging population. Through RCP2, CC-ABHI will provide up to $600,000 in funding per project to support those project costs directly associated with the trial testing of an innovative solution at an advanced stage of development within an aging population group in North America.  UofT Internal Deadline: March 23, 2017; Sponsor Deadline: March 30, 2017.
  • AGE-WELL 2017: Strategic Investment Program (SIP) Accelerator Funding. AGE-WELL is dedicated to the creation of technologies and services that benefit older adults and caregivers, with the aim of helping older Canadians maintain their independence, health and quality of life through technologies and services that increase safety and security, support independent living, and enhance social participation. The aim of the SIP Accelerator Program is to support innovative post-discovery projects focused on the commercialization and/or knowledge mobilization of solutions (e.g. technologies, services or policies) aligned with AGE-WELL's mission and vision. Up to $40,000 over 12 months. UofT Internal Deadline: April 21, 2017; Sponsor Deadline: April 28, 2017.
  • HUB Session: Interpreting Common StatisticsThis Seminar will cover how to analyze data and interpret results using methods such as the t-test, chi-squared test, linear and logistic regression. We will also explore the concepts behind hypothesis testing and confidence intervals. Registration is required. Date: March 6, 2017, 9:30am - 11:00 am. Details here.
  • Lab Equipment for Sale. The following two items are for sale. For more information please contact laura.riley@utoronto.ca, 416-978-8310
    • Forma Scientific: 6 ft Laminar flow hood with stand - certified until 2017. $2,000 or reasonable offer
    • Molecular devices: QPix 2 XT colony picker robot. $15,000 or reasonable offer.
  • Weston Brain Institute.
    • Transformational Research 2017. Funding (maximum of $1,500,000 over up to 3 years) for high-potential translational research projects with excellent preliminary data. Deadline EXTENDED to March 31, 2017.
    • Canada: Rapid Response 2017. Seed funding to support novel, high-risk, high-reward translational research that accelerates the development of therapeutics for neurodegenerative diseases of aging. Up to $200,000 per project, for up to 18 months. Deadline for PD-related disease applications: May 9, 2017; Deadline for AD-related disease applications: July 5, 2017.
    • Postdoctoral Scholars 2017. Funding (£57,000 per year for 2 years) to support top-tier Canadian postdoctoral scholars by providing salary support for international training at the University of Oxford and affiliation with Merton College. WEBINAR: March 7, 2017, 1pm-2pm; Deadline for applications: April 11, 2017.
  • Kidney Foundation of Canada: Alport Syndrome Research Funding Program. The objective of this research funding program is to advance the knowledge of, develop effective treatment protocols for, and discover a cure for Alport Syndrome Foundation. Funding will be provided for basic science or clinical research on Alport Syndrome. Deadline for Applications: March 29, 2017.
  • Alliance for Cancer Gene Therapy (ACGT): 2017 Investigator's Award in Clinical Translation of Cell and Gene Therapies for Cancer. ACGT is accepting grant applications to produce and release-testing of the clinical trial agents under cGMP, conduct the necessary pre-clinical pharmacological and toxicological studies in appropriate animal models, and/or conducting the clinical translational trials in patients in support of an Investigative New Drug (IND) application to the FDA. While the unambiguous demonstration of PRECLINICAL TREATMENT EFFICACY DATA IN TUMOR-BEARING ANIMALS in cancer treatment by cell and gene therapy is a pre-requisite, entering into the clinical trial during the funding period is also a requirement. Deadline for LOIs (abstracts): March 21, 2017.
  • Orphan Disease Centre (ODC) at the University of Pennsylvania: 2017 Pilot Grant Program for CDKL5 Deficiency. CDKL5 Deficiency is a monogenic, orphan condition characterized by treatment-resistant epilepsy and severe cognitive and motor disability. The ODC will provide a one-year grant for $150,000.00 (total cost) to support research related to CDKL5 – number of awards may vary. View the call for details. Deadline for LOIs: March 9, 2017.
  • Advancing Science through ​Pfizer: Investigator Research Exchange (ASPIRE) Gene Therapy for Hemophilia Research Awards Program. The 2017 ASPIRE Gene Therapy in Hemophilia Research Awards Program is designed to support laboratory and clinical research in pathogenesis, complications, management, and clinical outcomes of gene therapy for hemophilia. $125,000 USD per year for 1-2 years. Deadline for Applications: March 31, 2017.
  • The Rising Tide Foundation: Clinical Cancer Research Grants. Rising Tide Foundation supports truly innovative, unique, patient-centered research that has the potential to positively impact the lives of cancer patients in near future. They fund early stages clinical studies and translational research that can demonstrate the potential for quick and meaningful impact. They do not support basic research or phase III/IV trials. The amount of each award is based on availability of funds for up to 5 years. Deadline for Letters of Intent: April 20, 2017 or August 20, 2017.
  • Cystic Fibrosis Foundation: Research Grants. Research grants are intended to support basic science research. Studies may be carried out at the subcellular, cellular, animal or patient levels. To be considered, proposals must be hypothesis-driven and provide sufficient preliminary data to justify Cystic Fibrosis Foundation support. Upper amount $100,000 per year for up to two years. Deadline for Applications: April 19, 2017.
  • NIH Various Opportunities.  Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01) 
    • Advancing Our Understanding of the Brain Epitranscriptome (R21) and (R01)
    • Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01) and (R21)
    • Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01)
    • Secondary Data Analyses to Explore NIMH Research Domain Criteria (R03)
    • NCMRR Early Career Research Award (R03)
    • Oral HIV Vaccination: Strategy Synergistic to Systemic Vaccination (R01)
    • Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34)
    • Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01)
    • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)
    • HIV pathogenesis and the oral microbiota (R01)
    • Interaction of HIV and Neurodevelopment of Children in Resource-Limited Settings: Improving Assessments (R01) and (R21)
    • Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)
    • Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01)


February 13, 2017

  • Connaught Global Challenge Award 2017-18The Global Challenge Award program will support new collaborations with UofT researchers and students from multiple disciplines, along with innovators and thought leaders from other sectors, with the goal of heightening the University of Toronto's contribution to important issues facing society through the advancement of knowledge, and the transfer and application of solutions. Awards will support symposia, workshops, visiting scholars, and other mechanisms for bringing diverse sets of expertise to bear on important global challenges. Open to all UofT full-time professorial staff (tenured or tenured stream), the funding scheme will have an annual funding envelop of $750,000, with grants up to $250,000 each. Application Deadline: June 1, 2017.
  • 2017 NSERC Collaborative Research and Training Experience (CREATE):  INFORMATION SESSION. NSERC’s CREATE program awards grants of up to $1.65M over 6 years for the development of innovative training programs that enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce. Learn more about this program at our Information Session.  Dr. Luis Seco, a former CREATE Committee member will give insights on the program and the application process: 
    Monday February 27, 2017 3pm-5pm
    McMurrich Building, 12 Queen's Park Cres. West, Room 107
    Please RSVP by February 24th to joanna.baylon@utoronto.ca
  • Banting Research Foundation/McLaughlin Centre Discovery Award. The Banting Research Foundation and the University of Toronto McLaughlin Centre have announced a two-year funding partnership to support research by early career investigators focused on areas relevant to genomic medicine. Eligible applicants must be in the first three years of an academic appointment at the University of Toronto or its affiliated hospitals and their research institutes. 
    Institutional Support: the application must be accompanied by a letter of nomination from the applicant’s host department or division (note that a department/division head will be permitted to nominate only one potential applicant during each annual granting cycle). Applicants should contact their university or research institute departmental office concerning this nomination letter. Sponsor contact: Roman Rea (banting.foundation@utoronto.ca) 416-595-9046.
    Application Deadline: March 15, 2017.
  • CIHR Team Grant: Human Immunology Initiative: Standardization and its application in autoimmune diseases research. The aim of the Standardization Core is to create common measurements, indicators and outcomes that can be used for comparative purposes across populations and studies, including identifying and addressing ethical issues. The successful applicant to the Standardization Core funding opportunity will constitute a best practices platform, and will be responsible for the development and validation of standard operating procedures (SOPs) in human immunology, applied to the field of autoimmune disease research, by aligning with work conducted at the international level. A webinar will be announced at a later date. Deadline for Letters of Intent: June 6, 2017.
  • Canadian Liver Foundation: Operating Grant Program. In 2017, four operating grants may be awarded: 
    Two operating grants may be awarded to researchers in Canada whose research projects are related  to hepatobiliary research.
    One operating grant may be awarded to a researcher in Canada whose research project is related to liver cancer.
    One operating grant (sponsored by F. Pauline Spence) may be awarded to a researcher in Ontario whose research project is related to hepatobiliary research.
    Deadline for Applications: March 31, 2017.
  • Canadian Blood Services: 2017 MSM Research Grant Program. The objective of the MSM Research Program is to ensure the generation of adequate evidence-based research for alternative screening approaches for blood or plasma donors, which could evolve the current deferral policy for men who have sex with men (MSM) while maintaining the safety of the blood supply. Deadline for Registration: February 26, 2017: Application Deadline: April 30, 2017.
  • Alzheimer's Association: International Research Grant Program. The Alzheimer's Association funds a wide variety of investigations by scientists at every stage of their careers. Each grant is designed to meet the needs of the field and to introduce fresh ideas in Alzheimer's research. Deadline for Letters of Intent: March 1, 2017.
    • Research Grants (AARG)
    • Research Grants to Promote Diversity (AARG-D)
    • Research Fellowships (AARF)
    • Research Fellowships to Promote Diversity (AARF-D)
    • Clinician Scientist Fellowship (AACSF)
    • Clinician Scientist Fellowship to Promote Diversity (AACSF-D)
  • Cystic Fibrosis Foundation (CFF): Pilot and Feasibility Grants. The intent of these awards is to enable investigators to collect sufficient data to compete successfully for support from the NIH or other funding agencies. Special consideration will be given to those projects that propose innovative and creative approaches to the problems of cystic fibrosis. Applicants need not be U.S. citizens or hold a U.S. permanent visa to apply for this award. Deadline for Applications: April 19, 2017.
  • National Center for Responsible Gaming (NCRG): Large Grants for Research on Gambling Disorders. The Large Grants program provides support for discrete, specified, circumscribed research projects related to gambling disorders. Deadline for Letters of Intent: June 1, 2017. 


February 3, 2017

  • CIHR: JPIAMR Joint Call: Prevention and Intervention Strategies to Control AMR  Infections. The call targets research in the following topic: Comparison of prevention, control, and intervention strategies for AMR infections through multidisciplinary studies, including One Health approaches. Each transnational consortium is expected to include partners from at least 3 participating countries, but no more than 6. The total amount available for the Canadian component of successful projects is $3M, enough to fund approximately three (3) to five (5) grants. Read the call for complete details. Deadline for Pre-proposals: March 21, 2017; Deadline for Full Proposals: July 4, 2017.
  • LAUNCH: SickKids–CIHR-IHDCYH New Investigator Research Grants in Child and Youth Health. New Investigator Research Grants provide important early career development support to child health researchers. Grant recipients may obtain up to 3 years' support for research in biomedical, clinical, health systems and services, population and public health sectors. The maximum amount for a single grant is $100,000 per year for up to 3 years. Application Deadline: April 20, 2017.
  • CIHR: Health System Impact Fellowships. A NEW funding opportunity for PhD graduates (post-docs) who are interested in applying their research and analytic talents to critical challenges faced by health system and related organizations outside of the traditional scholarly setting, and who want to benefit from professional work experience, mentorship from health system and academic leaders, and professional development training in an expanded set of competencies (e.g., leadership, project management, change management) designed to accelerate professional growth. Application Deadline: May 9, 2017.
  • 2018 NSERC Collaborative Research and Training Experience (CREATE)The CREATE Program supports the training of teams of outstanding students and postdoctoral fellows from Canada and abroad through the development of innovative training programs that encourage collaborative and integrative approaches, address significant scientific challenges associated to Canada's research priorities, and facilitate the transition of new researchers from trainees to productive employees in the Canadian workforce. This year, the CREATE Program offers three additional opportunities within its current budget envelope. These include an Industrial Stream and an International Collaboration with Germany or Brazil. UofT Internal Deadline for LOIs: April 3, 2017 (FIRM): Sponsor Deadline: May 1, 2017.
    NSERC will be hosting two information sessions via webinar:
  • McLauglin Centre - Genomic Medicine Canada 2017: A symposium to discuss precision medicine initiatives.
    March 1, 2017, 8:30am - 5:00pm
    Sponsors: The University of Toronto McLaughlin Centre, Canada’s Genomic Enterprise (CGEn), and partners
    Location: Peter Gilgan Centre for Research and Learning Auditorium, The Hospital for Sick Children, 686 Bay Street, Toronto
    Information and registration here
  • uFluidix: Prototyping Grant (In-kind application competition): This no-strings-attached Prototyping Grant was developed for start-ups and individual inventors who have a novel product with a microfluidic component. The winners of the Prototyping Grant will obtain free design and fabrication services from uFluidix for the development of their microfluidic prototypes. The dollar value of offered services is USD 50,000 for one year. Questions should be directed to Kateryna Protskyk, Program Manager, The Microfuidic Circle.
  • Cancer Research Society: Scholarships for the Next Generation of Scientists - 2017 Competition. This initiative is aimed at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal.
    Part 1: Postdoctoral Salary Award -  1 year -  $40,000
    Part 2: Operating Grant  -   2 years - $120,000 ($60,000/year)
    Deadline for Applications: April 28, 2017
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Zika Virus (ZIKV) Complications (R21)
    • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)
    • Perception and Cognition Research to Inform Cancer Image Interpretation (R21) and (R01)
    • Juvenile Protective Factors and Their Effects on Aging (R01) and (R03)
    • Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)
    • Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)
    • Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21) and (R03) and (R01)
    • Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01) and (R21)
    • International Research in Infectious Diseases, including AIDS (R01)
  • Congressionally Directed Medical Research Programs (CDMRP) - Funding Opportunities. US Department of Defense (DOD) Office of the CDMRP has released pre-funding announcements for the following research programs: Multiple Sclerosis, Ovarian Cancer, Tuberous Sclerosis Complex, and Peer Reviewed Orthopaedic Research Programs. Descriptions of each of the funding opportunities, eligibility, key mechanism elements, and funding can be found in the respective Program pre-announcement at http://cdmrp.army.mil
  • Alzheimer's Drug Discovery Foundation (ADDF): Request for Proposal - Biomarkers Development. This RFP seeks to support the development and validation of novel and existing biomarkers that will enhance the design and performance of clinical trials for Alzheimer's disease, related dementias, and cognitive aging. The average award will be in the range of $150,000-$300,000 per year. The average award duration is 1-2 years. Deadline for LOIs: February 17, 2017 or May 19, 2017.
  • amfAR: Innovation Grants - Exploring the potential for HIV eradication. The purpose of this RFP is to fund biomedical research necessary to inform and design interventions to 1) cure HIV, defined by the eradication of all pathogenic virus from the body, or 2) bring about a state of remission whereby the virus is controlled in the absence of ART and the person is no longer infectious. Upper amount is $200,000 USD over 2 years. Registration Deadline: February 16, 2017; Deadline for LOIs: February 22, 2017.
  • Prostate Cancer Foundation: 2017 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer. These awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired. Team science awards are composed of at least three investigators from non-profit academic research centers, including one young investigator. They are intended to support large-scale research projects concerning metastatic, lethal prostate cancer over a duration of two years and provide up to $1 million USD per team. Deadline for Applications: April 24, 2017.​

January 19, 2017

  • Banting Research Foundation/Rick Hansen Institute Discovery Award. The Banting Research Foundation and the Rick Hansen Institute have announced a funding partnership to support research by early career investigators focused on areas relevant to spinal cord injury (SCI). This Discovery Award will support research which could potentially enable medical breakthroughs and transformative health care advances to reduce the human and economic costs associated with SCI. Eligible candidates must be focused on research in one or more of the following areas relevant to SCI: paralysis, pressure ulcers, urinary tract infections, neuropathic pain, predictive preclinical models of evaluation, and spinal cord injury in Indigenous Peoples in Canada. Eligibility is not limited to those specializing in the field of SCI, but the research must be applicable to SCI. Upper Amount $25,000. Deadline for Applications: March 15, 2017.
  • Big Data in Health and Biomedical Research - Call for Joint Projects. Tel Aviv University (TAU) - University of Toronto Joint Research Projects support and promote projects carried out collaboratively by TAU and UofT through identified fields of interest. The field of interest for this Call is Big Data in Health and Biomedical Research. Principal Investigators are invited to jointly submit proposals for the development of collaborative research projects and the exchange of researchers between TAU and UofT. Deadline for Proposals: March 9, 2017.
  • Ontario Brain Institute - 2017 ONtrepreneurs Program. This program provides an opportunity for Ontario's next generation of entrepreneurs to access much-needed funding and support for the launch or growth of their neurotechnology startup company. The 12-month program awards $50,000 cash and includes mentorship, training, and a number of value-add opportunities. UofT Internal Deadline: March 10, 2017; Sponsor Deadline: March 17, 2017.
  • CIHR Personalized Health Catalyst Grants (and INFORMATION WEBINAR). The purpose of this funding opportunity is to support researchers to maximize and leverage previous collaborative investments in personalized medicine, e-health and data platforms by driving evidence-based implementation of personalized health solutions that can contribute to more cost-effective and sustainable health care. Deadline for Registration: February 14, 2017; Application Deadline: June 13, 2017.
    INFORMATION WEBINAR: Friday, January 27, 2017; 1pm - 2pm ET.
    Webinar access (meeting number 550360853, password CIHR), Toll-free #: 1-877-413-4781; Conference code: 769 622 9
  • CIHR Team Grant: More Years / Better Lives (2017). The Joint Programming Initiative (JPI) “More Years, Better Lives – The Potential and Challenges of Demographic Change” seeks to enhance coordination and collaboration between European and national research programmes related to demographic change. This funding opportunity “Aging and place in a digitising world” is concerned with the ways in which the health and wellbeing of older people, at all stages of later life, is supported and promoted through the design of the social and physical environment, access to opportunities to learn, and the use of technologies of all kinds. Innovative, transnational and interdisciplinary collaborative projects that investigate the potential of technology, place and learning in relation with the older adult. Detailed information here.  Application Deadline: April 3, 2017.
  • HUB Session: Grants and Grantsmanship. This session provides information and tips on how to refine the clinical question and build a study rationale, identify core study team members as well as collaborators and infrastructure, communicate research impact and knowledge translation, and develop a study budget, identify considerations for study design, and frame a research question using the PICOT model. Registration is required. Date: January 23, 2017: 10-11:30am. Details here.
  • Prostate Cancer Foundation: 2017 PCF Young Investigator Awards. PCF Young Investigator Awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used flexibly to advance the career and research efforts of the awardee. Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients. View and dowload the RFA. Deadline for Applications: March 13, 2017, 3pm EDT.
  • NIH Update Font Guidelines for applications to due dates on or after January 25, 2017.
  • NIH: Various OpportunitiesUnless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Fertility Status as a Marker for Overall Health (R01) and (R21)
    • Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01)
    • HIV-1 infection of the Central Nervous System (R01)
    • NINDS Efficacy Clinical Trials (U01)
    • Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21) and (R01)
    • Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21) and (R01)
    • Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21) and (R01) 
    • Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
    • NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
    • Chronic Condition Self-Management in Children and Adolescents (R01) and (R21)
    • Reducing Health Disparities Among Minority and Underserved Children (R21) and (R01)
    • Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
    • NINDS Exploratory Clinical Trials (R01)
  • Human Frontier Science Program (HFSP) Research Grants: Young Investigators' Grants and Program Grants. Research grants are provided for teams of scientists from different countries who wish to combine their expertise in innovative approaches to questions that could not be answered by individual laboratories. Emphasis… more » is placed on novel collaborations that bring together scientists preferably from different disciplines (e.g. from chemistry, physics, computer science, engineering) to focus on problems in the life sciences. Registration Deadline: March 20, 2017; Deadline for LOIs: March 30, 2017.
  • Alzheimer's Research UK (ARUK): Global Clinical Trials Fund. The Global Clinical Trials Fund supports clinical trials that have potential to be of benefit to dementia patients. Lead applicants and trial sites can be from the UK or international. Deadline for EOIs: May 10, 2017. The remit of this scheme covers): 
    • ​Studies that aim to demonstrate target engagement, Phase I or Phase II clinical trials undertaken to ascertain the potential safety and efficacy of (novel or re-purposed) drug-based interventions in human subjects.  
    • Clinical trials of non-drug based, complex interventions.
    • Opportunities for research 'add ons' to ongoing clinical trials (e.g. biomarker add-ons)
  • ALS Association: Milton Safenowitz Post Doctoral Fellowship for ALS Research Awards. The ALS Association Research Investigator-Initiated Research Grant Program supports innovative research of high scientific merit and relevance to amyotrophic lateral sclerosis (ALS). Preliminary data is required and can be data generated in the PI's laboratory not necessarily generated by the applicant. All nationalities are welcome to apply and awards are made to non U.S.A. based investigators. The maximum amount awarded is $50,000 per year for 2 years. Deadline for Abstract Submissions: January 31, 2017; Application Deadline: March 24, 2017.
  • LGS (Lennox-Gastaut Syndrome) Foundation Research Grant Program. The LGS Foundation's seed grant program awards research grants to young investigators, physician residents, and clinicians who are interested in studying Lennox-Gastaut Syndrome (LGS), a rare and often debilitating form of childhood-onset epilepsy. Seed Grants $30,000 USD for a one-year grant. Post-Doctoral Fellowships are two-year grants up to $50,0000 USD ($25,000/year). International applicants are welcome to apply. Deadline for LOIs: March 1, 2017; Application Deadline: April 1, 2017.


January 5, 2017

  • 2017 Medicine by Design Postdoctoral Fellowship Awards. The 2017 Medicine by Design Postdoctoral Fellowship Award will provide funding to high-calibre candidates at the University of Toronto and its affiliated hospitals with outstanding potential to become independent researchers in the stem cell and regenerative medicine fields. Each award is up to a maximum of $50,000/year for three years towards salary support, from April 1, 2017 to March 31, 2020. Submission deadline is Monday January 30, 2017, 5 p.m. EST. Please note, the supervising Principal Investigator must submit the application, not the candidate, along with an MRA.
  • SickKids-CIHR New Investigator in Child and Youth Health: PRE-ANNOUNCEMENT. New Investigator Research Grants provide important early career development support to child health researchers. Grant recipients may obtain up to 3 years' support for research in biomedical, clinical, health systems and services, population and public health sectors. The maximum amount for a single grant is $100,000 per year for up to 3 years. It is intended that New Investigator Research Grants will enhance the grant recipient's ability to compete with more senior investigators for research grants from other funders. Application Deadline: April 20, 2017.
  • SSHRC Insight Development Grant information session. Research Services, UofT, will hold an information session on the upcoming SSHRC Insight Development Grant competition. The workshop will cover program and eligibility requirements, changes for 2017, evaluation criteria, proposal development and submission. A 2016 selection committee member will discuss the adjudication process and elements of a strong proposal.
    Wednesday, January 11, 2017 from 9:30am - 11am
    Governing Council Chamber, 27 King's College Circle, Simcoe Hall, 2nd Floor
    RSVP by noon January 10 to Sarah Scott at sja.scott@utoronto.ca
  • Important Deadlines - NSERC Engage program. NSERC has released the following announcement re: the Engage program: Per the revised quotas introduced by NSERC at the beginning of 2016, researchers are now limited to receive only one (1) Engage award per NSERC fiscal year. While their fiscal year does not end until March 31st, the NSERC Finance department closes in early March to permit year-end account reconciliations, and as a result no awards can be issued beyond that departmental closing date. Taking into account the time also needed to evaluate an application and complete the internal paperwork, the submission cut-off date for Engage applications hoping to qualify for a current-fiscal-year award is therefore much earlier than March 31st. As a result, Feb 17th is the last date for university research offices to click 'submit' for an Engage application for awards they would like considered for payment in the current (2016-17) NSERC fiscal year.​ View the Research Alert for further details.
  • Huntington Society of Canada: 2017 NAVIGATOR Research Competition. The goal of the NAVIGATOR Research Program is to provide funding for Canadian scientific research of direct and immediate relevance to Huntington Disease; to provide a platform for the future recruitment of outstanding investigators to HD research; to facilitate research collaboration nationally and internationally, and research which is relevant to other neurodegenerative disorders as well as HD. Deadline for LOIs (electronic and hard copy): February 9, 2017 at 3pm ET.
  • Grand Challenges Canada: Saving Lives at Birth - Round 6. Saving Lives at Birth partners are looking for Expressions of Interest for innovative approaches to address obstructions to healthy pregnancies and births in three areas: 1. Science & Technology 2. Service Delivery 3. "Demand side" Innovation. UofT Internal Deadline: February 21, 2017; Sponsor Deadline: February 24, 2017. Grants are available in three forms:
    • Seed Funding: The funding for these projects cannot exceed $250,000 over two years.
    • Validation Funding: The funding for these projects cannot exceed $250,000 over two years.
    • Transition Funding: The funding for these projects cannot exceed $2,000,000 over four years.

  • The Klarman Family Foundation (KFF): Eating Disorders Research Grants Program. In this application round the KFF are limiting the focus of their grants program to research that directly investigates the underlying biology of anorexia nervosa, and the questions of how and why it develops and persists. Please visit their website for further details. Amount/Duration is up to $750,000 over 3 years. Application Deadline: March 14, 2017.  
  • National Marfan Foundation (NMF): Faculty Grant Program. The faculty grant program supports two-year grants for basic or clinical research for all disciplines in Marfan syndrome and related disorders. Upper amount is $50,000 each year. Deadline for Proposals: April 21, 2017.

December 14, 2016

  • The Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE) and the Banting & Best Diabetes Centre (BBDC) in conjunction with the Vice-Dean, Research and Innovation, Faculty of Medicine are pleased to announce the 2017 AstraZeneca Impact Challenge Grant in Cardiovascular/Diabetes Research Competition.  The purpose of the grant is to foster bench to bedside translational research with a focus on innovation and first-in man clinical trials; to foster the training of graduate students across disciplines and research institutes; to establish the University of Toronto as an international leader in the study of diabetes and heart disease; and to encourage collaboration between the BBDC and the HSRLCE. One non-renewable award will be provided up to $250,000 ($125,000 annually for 2 years, to be spent over a maximum of 3 years). Funding for this competition will begin July 1, 2017. Deadline for applications: March 31, 2017.
  • Weston Brain Institute: Transformational Research 2017 - INFORMATION SESSION. Funding (maximum of $1,500,000 over up to 3 years) for high-potential translational research projects with excellent preliminary data that will advance the development of therapeutics for neurodegenerative diseases of aging. Deadline for LOIs: February 10, 2017.
    INFORMATION SESSION: January 19, 2017 at 1:00pm EST Register here.
     This session is intended to provide comprehensive information on the application process and to provide an opportunity for open questions.
  • Brain Canada and Huntington Society: “Creating HD Clinician-Scientist-to-Patient Virtual Networks” Multi-Investigator Research Initiative (MIRI). This joint initiative will support a three-year MIRI research project which connects clinicians, scientists, and the Huntington disease (HD) community, in a manner that can be demonstrated to create a collaborative HD Clinician-Scientist-to-Patient Virtual Network. 
    Workshop/ Teleconference Q&A Session: December 22, 2016 Details here.
    Deadline for Full Applications: February 2, 2017
  • Ontario-China Research and Innovation Fund (OCRIF): Call for Proposals (Biomaterials). The OCRIF has announced a new Call for Proposals open to projects that support scientific and technological collaboration projects between China and Ontario, with a current emphasis on biomaterials. Successful Ontario applicants will be eligible to receive a maximum of $250,000 per project from OCRIF to fund the Ontario portion of the project. Additional project funding will be provided to the corresponding Chinese applicant on each project by MOST to fund the China portion of the project. UoT Internal Deadline: January 23, 2017; Sponsor Deadline: January 30, 2017.
  • Mitacs Elevate: 2017 Call for Applications - Postdoc Funding in all Disciplines. Mitacs Elevate is a two-year training program for postdoctoral fellows in all disciplines, in which participants lead and undertake a research project in collaboration with a partner organization. During this time, fellows receive experiential training in R&D directly through their research collaboration and leadership training and business acumen through the program's training curriculum. With a suite of skills development retreats and activities unique to Mitacs Elevate, fellows learn about communication, leadership & management and other critical business skills relevant to research management careers in academia and industry. UofT Internal Deadline: February 15, 2017: Sponsor Deadline: February 22, 2017.
  • CIHR Funding Opportunities: Pre-Announcements:
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • BRAIN Initiative: Targeted BRAIN Circuits Projects - TargetedBCP (R01)
    • BRAIN Initiative: Exploratory Targeted BRAIN Circuits Projects - eTargetedBCP (R21)
    • Leveraging Existing Resources for Research on Lewy Body Dementia (R03)
    • Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01) and (R21)
    • Development of Multipurpose Prevention Technologies: A Strategy for the Prevention of Sexually Transmitted Infections (STIs) (R61/R33)
    • Pilot Clinical Trials Targeting HIV-1 Reservoirs in Children (U01)
    • Optimizing the HIV Care Continuum for Substance Abusing Populations at High-Risk and/or Living with HIV (R01)
    • Frontotemporal Degeneration FTD Sequencing Consortium: Discovery, replication and validation (UG3/UH3)
    • Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01)
  • Michael J. Fox Foundation for Parkinson's Research (MJFF): Edmond J. Safra Fellowship in Movement Disorders. The fellowship is open to movement disorder centers worldwide and can support both promising MD and MD/PhD applicants. The program is designed to expand the capacity of leading centers to train movement disorder fellows. To be eligible for the fellowship, applying centers must identify and support a new fellow. MJFF will award five two-year fellowships ($90,000 USD per fellow per year, $180,000 USD total). Deadline for Applications: January 4, 2017.
  • amFAR: RFP - Gene therapy to cure HIV. The purpose of this RFP is to develop a gene therapy-based approach to curing HIV. All proposed research must be directly and specifically relevant to developing a cure for HIV.  In the initial one-year period, each grant is funded at up to $400,000 USD including indirect costs at a maximum 20% rate.
    Registration Deadline: January 12, 2017; Deadline for LOIs: January 18, 2017.
  • Friedreich's Ataxia Research Alliance (FARA): General Research GrantsFARA supports research through funding competitive grants, promoting collaboration among scientists, advocating for public-private partnerships that support drug discovery, drug development and clinical research and hosting open forums for leading scientists to share their insights, ideas and challenges to advancing treatments for FA. The applicant may request a budget of up to $150,000 per year for one or two years. Deadline for LOIs: February 1, 2017.
  • New York Stem Cell Foundation (NYSCF). NYSCF will accept applications from researchers based at accredited non-profit research and academic institutions throughout the world. Each award provides up to $300K USD per annum for up to five years. Application Deadline: February 22, 2017.
  • Kenneth Rainin Foundation: Health - Innovator Awards (IBD). The Foundation supports research that is potentially transformative to diagnosing, treating and curing Inflammatory Bowel Disease. The Innovator Awards program provides grants for research projects, which due to their ground-breaking nature, may not be suitable for funding from more traditional sources, such as the National Institutes of Health (NIH). The grants are $100,000 USD for one year. Deadline for LOIs: February 15, 2017.
  • Jeffrey Modell Foundation: Translational Research Program (Primary Immunodeficiency). The Foundation encourages all investigators with the appropriate knowledge and research skill level to apply to this program. Applications submitted by investigators with vast expertise in Primary Immunodeficiency, as well as young investigators with robust scientific merit will all be considered. All international and U.S. applicants are eligible. The Foundation especially encourages investigators who are not currently receiving funding from the National Institutes of Health to apply.  Individual awards may total up to $250,000 USD over a two-year project period. Deadline for Applications: February 17, 2017.

November 29, 2016

  • Medicine by Design New Ideas Fund - New Tools & Devices. Medicine by Design is launching a New Ideas Fund to accelerate the rate of fundamental discoveries with potentially significant impact on stem cell and regenerative medicine research and translation. For the 2017 New Ideas RFA they are specifically interested in projects aimed at developing new tools, reagents and devices. View the RFA for priority areas. Proposals that articulate an interface with any of the funded MbD Cycle 1 Team Project Awards or proposals from investigators new to the regenerative medicine community are particularly encouraged. Each funded project will receive up to $100,000 per year, for a two-year period from April 1, 2017 to March 31, 2019. Deadline for Expressions of Interest: December 16, 2016.
  • CIHR and Health Canada: Operating Grants in Sugar and Health. The aim of this funding opportunity is to support research to examine sugars and health outcomes as well as population level approaches that contribute to reduced consumption of free sugars. The intent is to generate evidence that will inform nutrition policies and programs aimed at reducing dietary free sugar consumption to improve the health of the Canadian population.  WEBINAR: December 2, 2016 (French 2-3pm ET; English 3:30-4:30pm ET. To register email inmd.comms@sickkids.ca. Deadline for Applications: January 17, 2017.
  • Dairy Farmers of Canada (DFC) Call for Proposals - Dairy Research Cluster 3, (2018-2023). In preparation for the next Dairy Research Cluster application, DFC, in collaboration with its partners the Canadian Dairy Network (CDN) and Novalait Inc., is launching a "Call for Research Proposals". DFC invites all Canadian scientists to respond to this call. Dairy Research Cluster 3 – RESEARCH PRIORITIES: a) Sustainable Milk Production b)Human Nutrition and Health c) Dairy Genetics. Internal Deadline for Letters of Intent: January 2, 2017. Sponsor Deadline: February 1, 2017. 
  • HUB Session: Designing a Qualitative Study. 
    Dr. Janet Parsons and Natalie Baker
    Date: December 9, 2016, 10:30am - noon
    Online registration required
    Location: MS 2173, Medical Sciences Bldg, UofT, 1 King's College Circle
  • Alzheimer's Drug Discovery Foundation (ADDF): Requests for Proposals.
    • Program to Accelerate Clinical Trials (PACT) for Alzheimer's Disease: This program will fund biomarker-based pilot clinical trials for Alzheimer's disease, Phase I safety testing and IND-enabling studies to accelerate new drugs into trials. Through this PACT RFP, the ADDF is also interested in supporting clinical biomarker development programs and biomarker-based trials to validate putative mechanisms of action for targeted pharmacological and non-pharmacological approaches to prevention. Deadline for Letters of Intent: February 17, 2017.
    • Preclinical Drug Discovery RFP: The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising preclinical drug discovery and biomarker development programs relevant to Alzheimer's disease, other dementias and cognitive aging. Deadline for Letters of Intent: February 17, 2016.
  • ​Muscular Dystrophy UK: International call for Nemaline Myopathy 2016 (New). The call is open to all international researchers working on nebulin-related nemaline myopathy. Upper amount £225,000GBP over 3 years. Deadline for Applications: January 31, 2017.
  • Society of Surgical Oncology (SSO): Clinical Investigator Award. The purpose of this award is to promote patient-oriented research conducted by surgical oncologists in clinical and translational science. Of note, this award is not intended to serve as a career development award for new investigators seeking to initiate their research careers. The award will be funded for two years at $100,000 USD ($50,000 per year). Deadline for Applications: January 17, 2017. 
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01)
    • Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01) 
    • Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)
    • Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
    • Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)
    • Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)
    • Enhancing the Target and Biomarker Discovery Efforts of the AMP-AD and M2OVE-AD Consortia (R01)
    • Systems Biology: The Next Generation for Infectious Diseases (U19)
    • Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01)
    • Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimers Disease and Related Dementias (R01)
    • Investigator Initiated Extended Clinical Trial (R01) 
    • Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R01) and (R21/R33)


Back to Top